BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) 16% LOWER; announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft, to autograft for use in hindfoot and ankle fusion surgery. Click here for the full report.
Conseco, Inc. (NYSE: CNO) 14.2% HIGHER; announced today that, as part of a series of transactions intended to enhance its capital position, it entered into a stock and warrant purchase...
After-Hours Movers 10/13: CNO, MYRX, VOXX, INTC, GPI,...
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) 16% LOWER; announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully...
Unusual 11 Mid-Day Movers 12/15: (SPMD) (OKSB) (ZOLL)...
BioSante (Nasdaq: BPAX) 76.9% LOWER; says Libegel did not meet primary, secondary endpoints. Click here for the full report. The stock was downgraded at JMP, Jefferies, Leerink Swann, Rodman...
Morning Movers 05/10: (CKXE) (PKOH) (DF) (MED)...
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) 31.5% LOWER; reported Q1 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $390 thousand...
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
The X5 Stereo Bluetooth Headset is a portable multi-function device utilizing the latest cutting edge technologies allowing you to stream high quality music and make voice calls using a...
Uniden TRU9496 2-Line Corded/Cordless Digital...
With the Uniden TRU9496 5.8 GHz Digital 2-Line Expandable Phone System is the next generation of 5.8 GHz cordless phones. It's a full-featured digital answerer, with a Dialing keypad and a...
Post new comment